These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271. Wang R, Barmanray RD, Kyi M, Fourlanos S. Diabetes Care; 2024 Aug 01; 47(8):e61-e62. PubMed ID: 39052904 [No Abstract] [Full Text] [Related]
3. Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271. Vellanki P, Umpierrez GE. Diabetes Care; 2024 Aug 01; 47(8):e63-e64. PubMed ID: 39052906 [No Abstract] [Full Text] [Related]
6. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease. Zelnick LR, Batacchi ZO, Ahmad I, Dighe A, Little RR, Trence DL, Hirsch IB, de Boer IH. Diabetes Care; 2020 Oct 01; 43(10):2379-2387. PubMed ID: 32788282 [Abstract] [Full Text] [Related]
9. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study. Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E. J Diabetes; 2018 Apr 01; 10(4):276-285. PubMed ID: 29055090 [Abstract] [Full Text] [Related]
10. Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis. Chan CL, Hope E, Thurston J, Vigers T, Pyle L, Zeitler PS, Nadeau KJ. Diabetes Care; 2018 Jul 01; 41(7):1406-1413. PubMed ID: 29674323 [Abstract] [Full Text] [Related]
14. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis. Gallieni M, De Salvo C, Lunati ME, Rossi A, D'Addio F, Pastore I, Sabiu G, Miglio R, Zuccotti GV, Fiorina P. Acta Diabetol; 2021 Aug 01; 58(8):975-981. PubMed ID: 33743082 [Abstract] [Full Text] [Related]
15. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF. Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS. Front Endocrinol (Lausanne); 2024 Aug 01; 15():1293709. PubMed ID: 38379863 [Abstract] [Full Text] [Related]
16. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A. Clin Biochem; 2007 Dec 01; 40(18):1398-405. PubMed ID: 17919531 [Abstract] [Full Text] [Related]
17. Glycated albumin in diabetic patients with chronic kidney disease. Zheng CM, Ma WY, Wu CC, Lu KC. Clin Chim Acta; 2012 Oct 09; 413(19-20):1555-61. PubMed ID: 22579765 [Abstract] [Full Text] [Related]
18. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices. Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, Zhou R, Kohzuma T, Fonseca VA. J Clin Endocrinol Metab; 2020 Mar 01; 105(3):677-87. PubMed ID: 31650161 [Abstract] [Full Text] [Related]